Key facts
- This page summarizes Brian Achenbach's Form 4 filing for MUSTANG BIO, INC. (MBIO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2021, 15:30.
Brian Achenbach - 08 Dec 2021 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)
- Reporting relationship
- SVP, Fin. & Corp. Controller
- Issuer ticker
- MBIO
- Reported as of
- 08 Dec 2021
- Net transaction value
- -$8,004
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2021, 15:30:56 UTC
- Prior SEC filing
- 21 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Achenbach
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian Achenbach filed Form 4 for MUSTANG BIO, INC. (MBIO) on 16 Dec 2021.
Change
- Previous filing in this sequence was filed on 21 Oct 2021.
- Current net transaction value: -$8,004.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MBIO
transaction
COMMON STOCK
Award
- Transaction value
- $0
- Shares
- +22,500
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 149,103
- Date
- 08 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F4
MBIO
transaction
COMMON STOCK
Sale
- Transaction value
- $8,004
- Shares
- -4,374
- Change %
- -2.9%
- Price
- $1.83
- Shares after
- 144,729
- Date
- 14 Dec 2021
- Ownership
- Direct
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years.
Footnote F2
4,374 shares were sold in connection with the vesting of 13,750 shares on December 4, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Footnote F3
Represents the weighted average sales price.
Footnote F4
Includes restricted share units, which vest over various time periods.